157 related articles for article (PubMed ID: 12418415)
1. [Antiatherogenic effect of high density lipoprotein].
Turczyn B; Skoczyńska A
Postepy Hig Med Dosw; 2002; 56(4):499-520. PubMed ID: 12418415
[TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
3. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
4. The antiatherogenic role of high-density lipoprotein cholesterol.
Kwiterovich PO
Am J Cardiol; 1998 Nov; 82(9A):13Q-21Q. PubMed ID: 9819099
[TBL] [Abstract][Full Text] [Related]
5. [Lipid risk factors and their role in the pathogenesis of atherosclerosis].
Vaverková H
Vnitr Lek; 1996 Mar; 42(3):191-6. PubMed ID: 8686209
[TBL] [Abstract][Full Text] [Related]
6. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
[TBL] [Abstract][Full Text] [Related]
7. [Role of high density lipoproteins (HDL) in reverse cholesterol transport].
Ponsin G
Diabete Metab; 1991; 17(3):319-24. PubMed ID: 1884874
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.
Nofer JR; Brodde MF; Kehrel BE
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):726-35. PubMed ID: 20337657
[TBL] [Abstract][Full Text] [Related]
9. Should we routinely measure low-density and high-density lipoprotein subclasses?
Rizzo M; Berneis K; Zeljkovic A; Vekic J
Clin Lab; 2009; 55(11-12):421-9. PubMed ID: 20225664
[TBL] [Abstract][Full Text] [Related]
10. Differential abilities of mouse liver parenchymal and nonparenchymal cells in HDL and LDL (native and oxidized) association and cholesterol efflux.
Lapointe J; Truong TQ; Falstrault L; Brissette L
Biochem Cell Biol; 2006 Apr; 84(2):250-6. PubMed ID: 16609706
[TBL] [Abstract][Full Text] [Related]
11. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
12. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
Marcil M; O'Connell B; Krimbou L; Genest J
Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
[TBL] [Abstract][Full Text] [Related]
14. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
15. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins.
Mahley RW; Can S; Ozbayrakçi S; Bersot TP; Tanir S; Palaoğlu KE; Pépin GM
Am J Cardiol; 2005 Aug; 96(4):547-55. PubMed ID: 16098310
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of niacin.
Kamanna VS; Kashyap ML
Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
18. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
Hong SC; Zhao SP; Wu ZH
Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoproteins in the prevention of atherosclerotic heart disease. Part II. Biochemical role in the pathogenesis of atherosclerosis.
Berger GM
S Afr Med J; 1978 Oct; 54(17):693-7. PubMed ID: 217109
[TBL] [Abstract][Full Text] [Related]
20. Effect of HDL on the interaction of hyperlipemic LDL with monkey smooth muscle cells.
Bates SR
Artery; 1980; 7(4):303-15. PubMed ID: 7213019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
